These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 21918055

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Nanotechnology for the biologist.
    McNeil SE.
    J Leukoc Biol; 2005 Sep; 78(3):585-94. PubMed ID: 15923216
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging.
    Rhyner MN, Smith AM, Gao X, Mao H, Yang L, Nie S.
    Nanomedicine (Lond); 2006 Aug; 1(2):209-17. PubMed ID: 17716110
    [Abstract] [Full Text] [Related]

  • 28. Applications for site-directed molecular imaging agents coupled with drug delivery potential.
    Wang H, Chen X.
    Expert Opin Drug Deliv; 2009 Jul; 6(7):745-68. PubMed ID: 19552614
    [Abstract] [Full Text] [Related]

  • 29. Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics.
    Shi D, Bedford NM, Cho HS.
    Small; 2011 Sep 19; 7(18):2549-67. PubMed ID: 21648074
    [Abstract] [Full Text] [Related]

  • 30. The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis.
    Emerich DF, Thanos CG.
    Biomol Eng; 2006 Sep 19; 23(4):171-84. PubMed ID: 16843058
    [Abstract] [Full Text] [Related]

  • 31. Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis.
    Slevin M, Badimon L, Grau-Olivares M, Ramis M, Sendra J, Morrison M, Krupinski J.
    Mol Biosyst; 2010 Mar 19; 6(3):444-50. PubMed ID: 20174673
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Nano dot technology enters clinical trials.
    Friedman R.
    J Natl Cancer Inst; 2011 Oct 05; 103(19):1428-9. PubMed ID: 21934074
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery.
    Liu Y, Li K, Liu B, Feng SS.
    Biomaterials; 2010 Dec 05; 31(35):9145-55. PubMed ID: 20864169
    [Abstract] [Full Text] [Related]

  • 38. Molecular and magnetic resonance imaging: The value of immunoliposomes.
    Kozlowska D, Foran P, MacMahon P, Shelly MJ, Eustace S, O'Kennedy R.
    Adv Drug Deliv Rev; 2009 Dec 17; 61(15):1402-11. PubMed ID: 19796661
    [Abstract] [Full Text] [Related]

  • 39. The NCI Alliance for Nanotechnology in Cancer: achievement and path forward.
    Ptak K, Farrell D, Panaro NJ, Grodzinski P, Barker AD.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010 Dec 17; 2(5):450-60. PubMed ID: 20552623
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.